AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $42.95M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| CAE | Appendix 3B and S 708A Cleansing Statement | 13/04/18 | ||
| CAE | Piccadilly Drill Results Identify Larger Potential | PRICE SENSITIVE | 11/04/18 | |
| CAE | Half Year Accounts | 16/03/18 | ||
| CAE Appendix 3B and S 708A Cleansing Statement | |||
| 13/04/18 | |||
| CAE Piccadilly Drill Results Identify Larger Potential | |||
| 11/04/18 | PRICE SENSITIVE | ||
| CAE Half Year Accounts | |||
| 16/03/18 | |||
